Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 108 of the 110 references it cites were found in a registry or an index.

Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment

Open access

Abstract

Radiotherapy is an essential component of the treatment regimens for many cancer patients. Despite recent technological advancements to improve dose delivery techniques, the dose escalation required to enhance tumor control is limited due to the inevitable toxicity to the surrounding healthy tissue. Therefore, the local enhancement of dosing in tumor sites can provide the necessary means to improve the treatment modality. In recent years, the emergence of nanotechnology has facilitated a unique opportunity to increase the efficacy of radiotherapy treatment. The application of high-atomic-number (Z) nanoparticles (NPs) can augment the effects of radiotherapy by increasing the sensitivity of cells to radiation. High-Z NPs can inherently act as radiosensitizers as well as serve as targeted delivery vehicles for radiosensitizing agents. In this work, the therapeutic benefits of high-Z NPs as radiosensitizers, such as their tumor-targeting capabilities and their mechanisms of sensitization, are discussed. Preclinical data supporting their application in radiotherapy treatment as well as the status of their clinical translation will be presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules29112438

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 4 Enhanced cellular uptake of nanoparticles via targeting moieties. (A) Dark-field imaging of gold nanoparticles (yellow color) in MDA-MB-231 cells incubated with PBS (control), anti-CXCR4 functionalized GNPs (cGNP), or PEGylated GNPs (pGNP). Cell nuclei are stained in blue. (B) Cell uptake of rhodium-labeled folate functionalized AuNPs (Rho-FAx-AuNPs) by KB (overexpression of folate receptors) and MCF-7 (low expression of folate receptors) cells. AuNPs were functionalized with various surface concentrations of folate. Statistical significance was calculated versus non-targeted particles (Rho-Fa0 -AuNPs): **** p < 0.0001, ns nonsignificant. (C) Effects of PEG and RGD on the cellular accumulation of GNPs. Reproduced with permission from open access Creative Common license [16,28,30].
Figure 4 Enhanced cellular uptake of nanoparticles via targeting moieties. (A) Dark-field imaging of gold nanoparticles (yellow color) in MDA-MB-231 cells incubated with PBS (control), anti-CXCR4 functionalized GNPs (cGNP), or PEGylated GNPs (pGNP). Cell nuclei are stained in blue. (B) Cell uptake of rhodium-labeled folate functionalized AuNPs (Rho-FAx-AuNPs) by KB (overexpression of folate receptors) and MCF-7 (low expression of folate receptors) cells. AuNPs were functionalized with various surface concentrations of folate. Statistical significance was calculated versus non-targeted particles (Rho-Fa0 -AuNPs): **** p < 0.0001, ns nonsignificant. (C) Effects of PEG and RGD on the cellular accumulation of GNPs. Reproduced with permission from open access Creative Common license [16,28,30].CC BY · PubMed Central
Figure 6 Radiosensitization due to high-Z nanoparticles. (A) Normalized tumor volumes of MDA-MB-231 xenograft tumor-bearing mice post treatment with cGNP alone, radiation (10 Gy single dose) alone, pGNP + radiation (RT), or cGNP + RT (B) Survival fraction curves of CHO-K1 cells treated with AuNPs and irradiated at various doses with a 200 MeV proton beam. (C) Kaplan–Meier survival curves for U251 tumor-bearing mice treated with AuNPs or AgNPs with or without ionizing radiation (IR). Mice were irradiated with a single dose of 8 Gy with a 6 MV X-ray beam. Mice were treated with AgNPs at the same molar concentration (mol-AgNPs) or mass concentration (mas-AgNPs) as AuNPs. (D) Apoptosis of U251 cells after treatment with AgNPs or AuNPs combined with a radiation dose of 6 Gy. * p < 0.05, *** p < 0.001 compared with the control group. ## p < 0.01, ### p < 0.001 compared with the corresponding AuNPs-treated group (E) Tumor volume growth curves after treatment with HA-Gd2O3 NPs and radiation (R + HA-Gd). Mice were administered 3 fractions of 3 Gy with a 6 MeV beam over a 7-day period for a total of 9 Gy. Reproduced with permission from open access Creative Common license [28,74,75,76].
Figure 6 Radiosensitization due to high-Z nanoparticles. (A) Normalized tumor volumes of MDA-MB-231 xenograft tumor-bearing mice post treatment with cGNP alone, radiation (10 Gy single dose) alone, pGNP + radiation (RT), or cGNP + RT (B) Survival fraction curves of CHO-K1 cells treated with AuNPs and irradiated at various doses with a 200 MeV proton beam. (C) Kaplan–Meier survival curves for U251 tumor-bearing mice treated with AuNPs or AgNPs with or without ionizing radiation (IR). Mice were irradiated with a single dose of 8 Gy with a 6 MV X-ray beam. Mice were treated with AgNPs at the same molar concentration (mol-AgNPs) or mass concentration (mas-AgNPs) as AuNPs. (D) Apoptosis of U251 cells after treatment with AgNPs or AuNPs combined with a radiation dose of 6 Gy. * p < 0.05, *** p < 0.001 compared with the control group. ## p < 0.01, ### p < 0.001 compared with the corresponding AuNPs-treated group (E) Tumor volume growth curves after treatment with HA-Gd2O3 NPs and radiation (R + HA-Gd). Mice were administered 3 fractions of 3 Gy with a 6 MeV beam over a 7-day period for a total of 9 Gy. Reproduced with permission from open access Creative Common license [28,74,75,76].CC BY · PubMed Central
Figure 7 Dual radiosensitization through docetaxel-loaded gold nanoparticles. (A) Normalized tumor growth curves of 22RV1 xenograft tumor-bearing mice after irradiation of 6 Gy with 6 MeV electron beam. (B) Concentration of Au in 22RV1 xenograft tumor post-injection with Au-DUPA NPs or Au@DTX-DUPA NPs. (C) Cell cycle analysis of 22RV1 cells after treatment with Au-DUPA NPs, free DTX, or Au@DTX-DUPA NPs. (D) Ki67 staining assay of tumors 15 days post treatment to indicate proliferative capacity. * p < 0.05, ** p < 0.01. Reproduced with permission from open access Creative Common license [90].
Figure 7 Dual radiosensitization through docetaxel-loaded gold nanoparticles. (A) Normalized tumor growth curves of 22RV1 xenograft tumor-bearing mice after irradiation of 6 Gy with 6 MeV electron beam. (B) Concentration of Au in 22RV1 xenograft tumor post-injection with Au-DUPA NPs or Au@DTX-DUPA NPs. (C) Cell cycle analysis of 22RV1 cells after treatment with Au-DUPA NPs, free DTX, or Au@DTX-DUPA NPs. (D) Ki67 staining assay of tumors 15 days post treatment to indicate proliferative capacity. * p < 0.05, ** p < 0.01. Reproduced with permission from open access Creative Common license [90].CC BY · PubMed Central
Figure 1 Idea for using radiosensitizing high-Z NPs in radiotherapy treatment regimens. Prior to radiotherapy, high-Z NPs can be administered to the patient and allowed to accumulate in tumor tissue. This can increase the tumor’s sensitivity to radiotherapy, leading to enhanced tumor control for patients. (Created using Biorender.com).
Figure 1 Idea for using radiosensitizing high-Z NPs in radiotherapy treatment regimens. Prior to radiotherapy, high-Z NPs can be administered to the patient and allowed to accumulate in tumor tissue. This can increase the tumor’s sensitivity to radiotherapy, leading to enhanced tumor control for patients. (Created using Biorender.com).CC BY · PubMed Central
Figure 2 Passive targeting of NPs. (A) The poor structural integrity and lymphatic drainage of the tumor vasculature system result in the passive preferential accumulation of NPs in tumors compared with normal tissue. This is referred to as the EPR effect. (Created using Biorender.com). (B) Hyperspectral imaging demonstrating blood vessels facilitating the delivery of GNPs to the surrounding mice tumor tissue. Reproduced with permission from open access Creative Common license [16].
Figure 2 Passive targeting of NPs. (A) The poor structural integrity and lymphatic drainage of the tumor vasculature system result in the passive preferential accumulation of NPs in tumors compared with normal tissue. This is referred to as the EPR effect. (Created using Biorender.com). (B) Hyperspectral imaging demonstrating blood vessels facilitating the delivery of GNPs to the surrounding mice tumor tissue. Reproduced with permission from open access Creative Common license [16].CC BY · PubMed Central
Figure 3 Active targeting of NPs. (A) Many cancer cells overexpress various surface receptors in comparison with normal cells. The surface of NPs can be strategically modified with corresponding ligands to specifically bind to these receptors, increasing their uptake in cancer cells. (Created using Biorender.com). (B) Accumulation of cancer targeting GNPs in cancer cells versus normal fibroblasts. Cancer cells demonstrate greater accumulation of GNPs compared with normal fibroblasts due to their overexpression of targeted receptors. Top panel: hyperspectral imaging of GNPs. Bottom panel: confocal imaging of GNPs (red) and microtubules (green). Reproduced with permission from open access Creative Common license [20].
Figure 3 Active targeting of NPs. (A) Many cancer cells overexpress various surface receptors in comparison with normal cells. The surface of NPs can be strategically modified with corresponding ligands to specifically bind to these receptors, increasing their uptake in cancer cells. (Created using Biorender.com). (B) Accumulation of cancer targeting GNPs in cancer cells versus normal fibroblasts. Cancer cells demonstrate greater accumulation of GNPs compared with normal fibroblasts due to their overexpression of targeted receptors. Top panel: hyperspectral imaging of GNPs. Bottom panel: confocal imaging of GNPs (red) and microtubules (green). Reproduced with permission from open access Creative Common license [20].CC BY · PubMed Central
Figure 5 Mechanisms of high-Z NP radiosensitization. NPs can increase the sensitivity to radiation of cells through physical, chemical, and biological mechanisms. NPs interact with ionizing radiation, producing a shower of secondary electrons that can exert damage upon the cell. The electronically active surface NPs also catalyze the production of DNA-damaging ROS and free radicals, damaging critical cellular components. NPs can also increase the sensitivity of cells to radiation through oxidative stress and cell cycle effects. (Created using Biorender.com).
Figure 5 Mechanisms of high-Z NP radiosensitization. NPs can increase the sensitivity to radiation of cells through physical, chemical, and biological mechanisms. NPs interact with ionizing radiation, producing a shower of secondary electrons that can exert damage upon the cell. The electronically active surface NPs also catalyze the production of DNA-damaging ROS and free radicals, damaging critical cellular components. NPs can also increase the sensitivity of cells to radiation through oxidative stress and cell cycle effects. (Created using Biorender.com).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 110 references

Cited by

See all 52

Metadata

Authors
Jackson, N., Cecchi, D., Beckham, W., & Chithrani, D. B.
Affiliations
  • University of Victoria (CA)
  • University of British Columbia (CA)
Corresponding author
Chithrani, Devika B.
Venue
Molecules
Publisher
MDPI AG
Published
2024-05-22
Volume
29
Issue
11
Pages
2438
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4398207790
Cited by
52
References
110
Citations by year
2026: 28 · 2025: 22 · 2024: 2
FWCI
3.84
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • cIRcle (University of British Columbia) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • UVic’s Research and Learning Repository (University of Victoria) (submittedVersion, cc-by)
  • Open Collections
Funders
  • Nanomedicines Innovation Network (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
  • Natural Sciences and Engineering Research Council (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
  • Canadian Institute for Health Research (2021-RES-SI-05, RGPIN-2017-04501, CIHR PJT-399879)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Keywords
high-Z nanoparticles, radiosensitizers, radiotherapy, tumor targeting, radiosensitivity, targeted drug delivery, dose escalation, radiation toxicity, clinical translation
MeSH terms
Animals, Humans, Neoplasms, Radiation-Sensitizing Agents, Radiotherapy, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment. https://app.cochat.ai/papers/10.3390/molecules29112438
The paper
Jackson, N., Cecchi, D., Beckham, W., & Chithrani, D. B. (2024). Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment. Molecules. https://doi.org/10.3390/molecules29112438

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.